Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/08/2003EP1349542A1 Amoxycillin pellets
10/08/2003EP1227808B1 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
10/08/2003EP1207901B1 Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1074556B1 Phosphonic acid diester derivatives
10/08/2003EP0966245B1 Antimicrobial cosmetic compositions
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003EP0551460B2 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV)
10/08/2003CN1447812A Process for prepn. of highly pure crystalline (R.S)-cefuroxime axetil
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447808A Oxazolidinone derivatives as anticrobials
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1447695A Potent immunostimulants from microalgae
10/08/2003CN1447692A Methods of drug delivergy to hepatocytes and treatment of flaviviridae infections
10/08/2003CN1447682A Amphotericin B structured emulsion
10/08/2003CN1446822A Acidic antibacterial peptides and gene as well as its application in pharmacy
10/08/2003CN1446821A Active antibiotics dodeca peptide
10/08/2003CN1446579A Medicine for treating sexually transmission disease
10/08/2003CN1446570A Externally applied agent for preventing infectious disease in respiratory tract as well as preparation method
10/08/2003CN1446559A Medicine for treating common cold and its preparation method
10/08/2003CN1446553A Medicine for treating chromic avidity, persistent hepatitis B and its preparation method
10/08/2003CN1446542A Compound preparation for preventing and treating typical model pneumonia and other virus infection diseases
10/08/2003CN1123574C Ligands for FLT3 receptors
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/08/2003CA2424683A1 Hla matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/07/2003US6630582 Isolated nucleic acid, of given sequence, which encodes a catalase; gastroduodenal diseases
10/07/2003US6630579 Complex
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630484 6-and 7-substituted analogs of swainsonine their preparation and therapeutic use
10/07/2003US6630481 Phototherapeutic and catalytic photoactivated DNA cleaving agents
10/07/2003US6630477 Therapeutic nucleoside compound
10/07/2003US6630470 G-CSF mimetics
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630455 Methods for inducing mucosal immune responses
10/07/2003US6630453 Androgen derivatives and uses thereof
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630147 Pseudomycin natural products
10/07/2003US6630144 Monoclonal antibodies to Ebola glycoprotein
10/07/2003US6630138 Protein C derivatives
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2258146C Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2208520C Diclavulanate salt with a diamino ether and process of preparation
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA2074004C 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080823A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003WO2003080817A1 Process for producing cytotoxic lymphocyte
10/02/2003WO2003080794A2 Inhibition of rna function by delivery of inhibitors to animal cells
10/02/2003WO2003080678A1 Modified saccharides having improved stability in water
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080633A1 Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
10/02/2003WO2003080620A1 Inhibitors of nucleoside phosphorylases and nucleosidases
10/02/2003WO2003080612A1 Dipyridodiazepinones as reverse transcriptase inhibitors
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003WO2003080552A2 Cyclopentenone derivatives, their preparation and use in medecime
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080113A1 Mucosal immune vaccine for periodontal diseases
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080109A1 Use of hydrogen peroxide producing enzyme for treatment of otitis media
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080089A1 Bioactive hexane fraction from vetiveria zizanioides
10/02/2003WO2003080082A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
10/02/2003WO2003080080A1 Cyclodextrin compositions and methods of treating viral infections
10/02/2003WO2003080078A1 Treatment of pre-core hepatitis b virus mutant infections
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080059A1 Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080052A1 A use of treatment for fungal infections with a synergistic formulation of antifungal agents
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003079981A2 Bioadhesive drug delivery system
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079923A1 Method of administering an injectable antibiotic to the ear of an animal
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003062394A9 Methods and compositions for rna interference
10/02/2003WO2003061577A3 Polyalkylene glycol with moiety for conjugating biologically active compound
10/02/2003WO2003050139A3 Prion inhibiting peptides and derivatives thereof
10/02/2003WO2003039529A8 Selective antibacterial agents
10/02/2003WO2003031599A3 Live attenuated salmonella strains for producing vaccines
10/02/2003WO2003020206A3 Use of atazanavir in hiv therapy
10/02/2003WO2003018031A3 Single dose azithromycin for treating respiratory infections
10/02/2003WO2003013593A3 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
1 ... 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 ... 1798